Top compounds associated with response to CT62


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0082 0.8
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0083 0.8
mRNA MST-312 CTRPv2 pan-cancer AAC 0.008 0.8
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0084 0.8
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.0064 0.8
mRNA AEW541 CCLE pan-cancer AAC -0.01 0.8
mRNA alisertib CTRPv2 pan-cancer AAC -0.0065 0.8
mRNA AT7867 CTRPv2 pan-cancer AAC -0.0072 0.8
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.01 0.8
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC -0.0076 0.8
Download CSV